EarlyHealth Group (EHG) is a global pharmaceutical service provider supporting clinical research and market access in the life sciences industry. For the past four decades, EHG has collaborated with biotech, pharmaceutical companies and CRO’s in delivering a spectrum of clinical trial services and managed access solutions in more than sixty countries.
Through a blend of organic growth and external acquisitions, our group has evolved to over 40 companies, seamlessly integrated to support your development at every stage of the way.
EarlyHealth Group has 3 GMP manufacturing sites for clinical trial primary and secondary packaging, along with multiple GDP warehouses, operating sites and offices globally. Throughout the years, we have strengthened our geographic offerings ensuring global trials and patient programs can be managed inhouse.